139 related articles for article (PubMed ID: 25047009)
1. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas.
Inagaki Y; Seyama Y; Hasegawa K; Tang W; Kokudo N
Drug Discov Ther; 2014 Aug; 8(4):173-7. PubMed ID: 25047009
[TBL] [Abstract][Full Text] [Related]
2. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
4. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas.
Tajiri T; Tate G; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohosh T
Pancreas; 2004 Aug; 29(2):116-22. PubMed ID: 15257103
[TBL] [Abstract][Full Text] [Related]
5. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases.
Fukushima N; Mukai K; Sakamoto M; Hasebe T; Shimada K; Kosuge T; Kinoshita T; Hirohashi S
Virchows Arch; 2001 Jul; 439(1):6-13. PubMed ID: 11499841
[TBL] [Abstract][Full Text] [Related]
6. Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas.
Okada K; Hirabayashi K; Imaizumi T; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
Biomed Res; 2010 Feb; 31(1):13-9. PubMed ID: 20203415
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.
Ohtsuki Y; Watanabe R; Kimura M; Nomura K; Maeda T; Kito K; Takeji M; Lee GH; Furihata M
Med Mol Morphol; 2015 Jun; 48(2):85-91. PubMed ID: 24908068
[TBL] [Abstract][Full Text] [Related]
8. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
[TBL] [Abstract][Full Text] [Related]
9. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
[TBL] [Abstract][Full Text] [Related]
10. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
[TBL] [Abstract][Full Text] [Related]
11. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
13. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasm involving pancreaticobiliary maljunction and an aberrant pancreatic duct draining into the stomach: A case report and review of the literature.
Kinowaki Y; Takazawa Y; Yamamoto N; Ishikawa Y
Pathol Res Pract; 2016 Feb; 212(2):139-44. PubMed ID: 26611763
[TBL] [Abstract][Full Text] [Related]
15. MUC1 and HER2 might be associated with invasive phenotype of intraductal papillary mucinous neoplasm.
Ohira G; Kimura K; Yamada N; Amano R; Nakata B; Doi Y; Murata A; Yashiro M; Tanaka S; Ohsawa M; Wakasa K; Hirakawa K
Hepatogastroenterology; 2013; 60(125):1067-72. PubMed ID: 23635475
[TBL] [Abstract][Full Text] [Related]
16. Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas.
Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Seki S; Hirakawa K
Int J Cancer; 2002 Dec; 102(6):655-9. PubMed ID: 12448010
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.
Kim J; Jang KT; Mo Park S; Lim SW; Kim JH; Lee KH; Lee JK; Heo JS; Choi SH; Choi DW; Rhee JC; Lee KT
Tumour Biol; 2011 Jun; 32(3):535-42. PubMed ID: 21190101
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
[TBL] [Abstract][Full Text] [Related]
20. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
Lüttges J; Zamboni G; Longnecker D; Klöppel G
Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
